These pilot programs will invite men at risk of PCa and will apply individual retesting intervals, using PSA testing for initial screening and follow-up tests with risk calculators and magnetic resonance imaging before prostate biopsy [5]. This evidence concerns the gene KLK3 and posterior cortical atrophy.